Organogenesis (Nasdaq: ORGO) said it completed a Type B meeting with the FDA and received confirmation that the ReNu clinical development program is appropriate for a rolling Biologics License Application (BLA) submission expected by the end of 2025. The program includes two large Phase 3 randomized controlled trials, extensive commercial history, and RMAT designation.
The company plans to initiate a rolling BLA for ReNu before the end of December and said, if approved, ReNu could address knee osteoarthritis pain for millions of patients.
Soccer mega-fan Mayor Zohran Mamdani signed an emergency order that will block events including some concerts and food festivals from city parkland during the FIFA World Cup.
The city Parks Department adopted the rule at the request of the NYPD, denying new permits for special events on park property during thetournament, which runs from June 11 to July 19.
NYC Mayor Zohran Mamdani made an infrastructure improvement announcement inside Sunset Park in Brooklyn on March 31, 2026.Paul Martinka for New York Post
The directive could block any events with 20 or more people that require the special permits which could even include birthday celebrations at the Big Apple’s 100 featured parks.
However, critics contend it wouldn’t be necessary if City Hall did a better job hiring officers to fill the NYPD’s depleted ranks — and worked on keeping cops from fleeing the force.
“Police officers are already burned out by the short-staffing they experience on a daily basis,” Hendry said. “When this summer’s massive workload hits, it’s going to push even more of them out the door.”
City Councilman Frank Morano (R-Staten Island) agreed.
“New York used to be the city that never sleeps,” said Morano, who sits on the council’s parks committee. “Now it’s the city that cancels. If we had the police staffing we should have, families wouldn’t be paying the price for City Hall’s mismanagement.”
The New York City Parks Department adopted an emergency rule denying permits for events on park property during the FIFA World Cup tournament, which runs from June 11 to July 19.REUTERS
The USTA Billie Jean King National Tennis Center at Flushing Meadows-Corona Park in Queens, New York, is pictured on Jan. 4, 2024.Domingo Sáez – stock.adobe.com
NYC Parks said it adopted the rule denying or restricting “special events” at the request of the police force because manpower will be stretched patrolling events tied to the soccer tournament as well as events commemorating America’s 250th anniversary.
“To more effectively deploy resources and control overtime costs, the NYPD has recommended that the department deny certain permit applications for new events between June 11, 2026 and July 19, 2026,” the parks agency said.
Applications for events not held last year could be rejected.
About 1.2 million visitors are expected to converge on the New York metro region for eight World Cup games at MetLife Stadium at the Meadowlands in New Jersey.NYPCS for the New York Post
But permits for demonstrations will be exempt from the rule, the agency said.
“The events associated with the FIFA World Cup and United States 250th anniversary will require significant realignment and deployment of NYPD personnel, which will further divert resources from regular assignments and from crime-fighting, public safety, and counter-terrorism duties,” according to the rule, which was signed by Mamdani and Parks Commissioner Tricia Shimamura.
Before NYC Parks decides on special permit applications, they will consult the NYPD to determine if resources are available to patrol the events.
“This is outrageous — besides making no sense,” one Big Apple event planner told The Post on Monday. “Normally, during the summer months, there would be over 1,000 new events where the city takes in millions of dollars.
“That money could’ve been used for [Mamdani’s] budget deficit,” the planner said. “Maybe he should hire an accountant.”
About 1.2 million visitors are expected to converge on the New York metro region for eight World Cup games at MetLife Stadium at the Meadowlands in New Jersey. Many fans will stay at Big Apple hotels.
Another 6 million visitors are expected for events around the 250th anniversary of the country, with which Fleet Week will coincide this year.
There are already a number of related gatherings planned locally.
The NYNJ World Cup 26 Fan Zone Queens will take place at the USTA Billie Jean King National Tennis Center’s Louis Armstrong Stadium from June 17–28. In addition to live match broadcasts, the Fan Zone will include entertainment, games, local food vendors, official merchandise, VIP hospitality experiences and more.
FIFA Fan Festival NYNJ will be held at Liberty State Park in New Jersey throughout the tournament, with live match screenings, music, celebrity appearances and other family-friendly programming.
U.S. Health Secretary Robert F. Kennedy Jr. is rewriting the rules of membership for a key vaccine advisory panel, according to a document published by his department on Monday, after a judge last month declared most of his prior selections unqualified and put their decisions on hold.
The Advisory Committee on Immunization Practices, which advises the Centers for Disease Control and Prevention on the use of vaccines, had been a major tool in Kennedy's efforts to reshape U.S. vaccine policy.
In a March 16 decision, Boston-based U.S. District Judge Brian Murphy concluded that ACIP had been unlawfully reconstituted after Kennedy, a longtime anti-vaccine activist, last year removed and replaced all 17 independent experts who previously served on the panel, adding several members who share his controversial vaccine views.
In his decision, Murphy concluded that Kennedy's ACIP panel violated the Federal Advisory Committee Act and repeatedly pointed to the panel's charter, which required that its members have expertise in the use and research of vaccines and immunization practices.
On Monday, the Department of Health and Human Services led by Kennedy published a renewal of the charter that broadens the list of expertise for individuals who could serve on that panel, which makes recommendations impacting the use of vaccines, including the U.S. childhood immunization schedule.
A previous version of the charter signed by Kennedy in December stipulated that panel members should be knowledgeable about immunization practices and public health, and have expertise using vaccines in clinical practice or preventive medicine or have expertise in vaccine research, or in vaccine efficacy and safety.
Two former ACIP members appointed by previous administrations said the new charter appears to broaden the requirements for membership, listing examples of specialists in biostatistics and toxicology.
In his decision, Murphy said the members Kennedy appointed were "distinctly unqualified," with only six of the 15 members having any meaningful experience in vaccines.
HHS spokesman Andrew Nixon downplayed the significance of the changes, saying the ACIP charter renewal and publication "are routine statutory requirements and do not signal any broader policy shift."
The revamped charter followed a letter sent to Kennedy on March 25 by attorney Aaron Siri representing Informed Consent Action Network, a group critical of vaccine safety and mandates, recommending changes to the ACIP charter.
According to a press release on the ICAN website promoting the letter, the group called on Kennedy to "clarify committee member criteria" and argued that all 13 of the ACIP members whose qualifications were challenged in Murphy's decision "do have the requisite experience."
So far, the Trump administration has not appealed Murphy's ruling, but still has time to do so under a 60-day window.
A spokesperson for Iran's Khatam al-Anbiya Central Headquarters Ebrahim Zolfaghari said on Monday that Iran will launch its largest attacks since the start of the war.
"Tonight and tomorrow night, Iran will carry out its most extensive attacks since the beginning of the war against the United States, the Israeli regime, and their regional allies," Zolfaghari wrote on X.
The warning comes after US President Donald Trump threatened that "the entire country [Iran] can be taken out in one night," adding that "that night might be tomorrow night," and described Tuesday's deadline as "final." He also warned Iran's infrastructure could be destroyed "over a period of four hours" if no deal is reached.
A federal appellate court has agreed to reinstate a $656 million judgment against Palestinian authorities for Americans killed or wounded in attacks by the Palestinian Liberation Organization (PLO) and the Palestinian Authority while in Israel.
The ruling from the 2nd U.S. Circuit Court of Appeals was issued in the wake of a Supreme Court decision authorizing such suits for victims of international terrorism in a legal saga that’s been ongoing since the mid-2010s.
“We conclude that the original judgment for the plaintiffs should be reinstated. That conclusion is consistent with the plain import of the Supreme Court’s decision,” the judges said in a decision dated March 30.
The Supreme Court’s decision directly overturned a prior ruling made by the 2nd Circuit Court of Appeals on the matter.
The case has its earliest origins in a law passed by Congress in 1992, the Anti-Terrorism Act, which permitted victims of international terror to sue the offender.
In 2014, in the case Sokolow v. PLO, the PLO was successfully sued under that law in the U.S. District Court for the Southern District of New York. In the case, victims were awarded $218.5 million in damages by a jury—tripled to $655.5 million under the Anti-Terrorism Act.
The victims and their families have stated that Palestinian agents were either directly involved in the attacks or helped incite them.
The Palestinians have consistently argued that the cases shouldn’t be allowed in American courts.
In 2016, the case was brought before the 2nd Circuit Court of Appeals. In their decision, circuit judges tossed out the verdict from the lower court, and ruled that U.S. courts had no jurisdiction over international actors in non-U.S. countries.
Frustrated by the ruling, Congress in 2019 passed the Promoting Security and Justice for Victims of Terrorism Act (PSJVTA), which sought to create a legislative carve-out to ensure that lawsuits against the PLO and Palestinian Authority could move forward.
The legislation stated that the PLO and Palestinian Authority had “consented” to the jurisdiction of U.S. courts if they either paid martyr benefits to terrorists or their families or if they maintained any non-United Nations offices in the United States.
In 2023, the matter came again before the 2nd Circuit Court of Appeals, and the court held that the PSJVTA was unconstitutional. Its ruling stated that Congress could not simply “deem” an action to constitute consent to U.S. jurisdiction without running afoul of the Due Process Clause of the Fifth Amendment.
In a unanimous decision in June 2025, the Supreme Court ruled in favor of victims, overturning the 2nd Circuit Court of Appeal’s ruling that the Fifth Amendment was violated by the PSJVTA.
With the vacation overturned, the courts will now move toward enforcement of the lower court ruling in favor of the plaintiffs, although collecting the funds from the PLO may meet with practical obstacles.
The Centers for Medicare & Medicaid Services released the Calendar Year (CY) 2027 Medicare Advantage (MA) and Part D Rate Announcement today to improve payment accuracy across both programs. The finalized policies also advance CMS’ vision of a sustainable and stable MA program that offers choice to Medicare beneficiaries and is a responsible steward to taxpayers.
The policies in this Rate Announcement are projected to result in a net average increase of 2.48%, or over $13 billion in additional MA payments to plans in CY 2027. This expected increase includes consideration of the various elements that impact MA payments, such as growth rates of underlying costs, 2026 Star Ratings for 2027 quality bonus payments, and risk adjustment updates.
“Medicare Advantage and Part D should work for the people who rely on them,” said CMS Administrator Dr. Mehmet Oz. “These updates keep coverage affordable and ensure patients get real value from their plans.”
CMS is committed to ensuring Medicare beneficiaries are free to choose the health coverage that best meets their needs, and that such coverage maximizes value. Establishing accurate payments in MA and Part D is foundational to this objective and will enable the agency to maintain affordable Medicare coverage while acting as good stewards of a more sustainable and credible program over the long term.
“CMS’ vision for Medicare Advantage and Part D is clear: a great choice for seniors and a smart deal for taxpayers,” said Chris Klomp, Director of Medicare and Chief Counselor of the U.S. Department of Health and Human Services. “The Rate Announcement improves payment accuracy and strengthens competition based on quality—not on coding practices—helping put the program on a more sustainable path for the long term.”
The policies in the Rate Announcement address coding differentials between MA and Original Medicare for CY 2027. CMS is working towards a MA risk adjustment system guided by three principles: (1) simplicity to reduce day-to-day administrative burden for both plans and providers; (2) competition for all plans irrespective of size or resources, creating greater value for patients; and (3) achieving payments that accurately reflect beneficiary health risk and facilitate the efficient use of healthcare resources, enhanced program integrity, and greater accountability. Working towards a risk adjustment system guided by these principles will promote a more stable and sustainable MA program in the long run by giving beneficiaries and taxpayers confidence that CMS is mitigating unnecessary cost growth from coding practices that do not lead to better quality coverage.
In consideration of the impact that the 2024 MA risk adjustment model had between CY 2024 and CY 2026, CMS will continue using the 2024 MA risk adjustment model for CY 2027. The agency will evaluate the public feedback received as it considers future updates to the MA risk adjustment model.
CMS is excluding diagnosis information from unlinked chart review records, which is diagnosis information not associated with a specific beneficiary encounter, from risk score calculation starting in CY 2027, with an exception for beneficiaries who switch from one MA organization to another. As a result, aside from the exception, diagnoses that are not associated with a service will not be considered for risk adjustment. CMS expects the payment impact to be greater for MA organizations that heavily rely on unlinked chart review records to report risk-adjustment eligible diagnoses for their enrollee population.
CMS is finalizing updates to the Part D risk adjustment model that include accounting for Inflation Reduction Act changes to the Part D benefit for CY 2027, reflecting more current costs, and separately accounting for MA prescription drug plan and standalone prescription drug plan costs in order to improve the accuracy of Part D payments for these two segments of the Part D market. Additionally, CMS is aligning sources of diagnoses for use in risk adjustment to be consistent with similar policies finalized for MA (e.g., excluding diagnoses from unlinked chart review records, with an exception for beneficiaries who switch from one MA organization to another). These updates will bring additional stability to prescription drug benefits for all Medicare beneficiaries.
